[GOAL] Elsevier's interpretation of CC BY-NC-ND

Jevan Pipitone email1 at jevan.com.au
Sun Jun 18 18:46:06 BST 2017


Sorry - sending this again - since I forgot to add the list email to it.

Re: Creative Commons-Attribution-Noncommercial-No Derivatives (CC-BY-NC-ND)

The fact that it says "No Derivatives" seems a concern for example 
sometimes researchers can publish a summary of other peoples articles 
and then include all the articles used in the references. But if it says 
"No Derivatives" does this mean the articles written by other people 
cannot be used to contribute towards your research, in which case, what 
is the point in reading them? Also part of the point of reading an 
article is to gain ideas from other people which can then be used to 
create new things by the researcher, but, this is potentially a 
"derivative" work since it can build on the work of others. So I think 
there is a problem there too.

Jevan.

On Sun 18-Jun-17 10:29 PM, Richard Poynder wrote:
>
> On a related topic, this poster might be of interest to list members:
>
>
> *Exploiting Elsevier’s Creative Commons License Requirement to Subvert 
> Embargo*
>
> *
> *
>
> "In the last round of author sharing policy revisions, Elsevier 
> created a labyrinthine title-by-title embargo structure requiring 
> embargoes from 12-48 months for author sharing via institutional 
> repository (IR), while permitting immediate sharing via author's 
> personal website or blog. At the same time, all pre-publication 
> versions are to bear a Creative Commons-Attribution-Noncommercial-No 
> Derivatives (CC-BY-NC-ND) license.
>
>
> "At the time this policy was announced, it was rightly criticized by 
> many in the scholarly communication community as overly complicated 
> and unnecessary. However, this CC licensing requirement creates an 
> avenue for subverting the embargo in the IR to achieve quicker open 
> distribution of the author's accepted manuscript.
>
>
> "In short, authors may post an appropriately licensed copy on their 
> personal site, at which point we may deposit without embargo in the 
> IR, not through the license granted in the publication agreement, but 
> through the CC license on the author's version, which the sharing 
> policy mandates. This poster will outline this issue, our 
> experimentation with application, and engage viewers in questions 
> regarding its potential risks, benefits, and workflows."
>
> https://kuscholarworks.ku.edu/handle/1808/24107
>
>
>>
>
> On 18 June 2017 at 12:24, Mittermaier, Bernhard 
> <b.mittermaier at fz-juelich.de <mailto:b.mittermaier at fz-juelich.de>> wrote:
>
>     Dear colleagues,
>
>     on sharing in file-sharing networks, Creatice Commons explain:
>
>     “Can I share CC-licensed material on file-sharing networks?
>
>     Yes. All CC licenses allow redistribution of the unmodified
>     material by any means, including distribution via file-sharing
>     networks. Note that file-trading is expressly considered to be
>     noncommercial for purposes of compliance with the NC licenses.
>     Barter of NC-licensed material for other items of value is not
>     permitted.”
>
>     https://creativecommons.org/faq/#can-i-share-cc-licensed-material-on-file-sharing-networks
>     <https://creativecommons.org/faq/#can-i-share-cc-licensed-material-on-file-sharing-networks>
>
>
>     The “Elsevier Sharing Rules” say
>
>     “CC-BY-NC-ND licensed articles may be shared on non-commercial
>     platforms only.”
>
>     http://help.sciencedirect.com/flare/sdhelp_Left.htm#CSHID=password.htm|StartTopic=Content%2Fsharing_pubs.htm|SkinName=svs_SD
>     <http://help.sciencedirect.com/flare/sdhelp_Left.htm#CSHID=password.htm%7CStartTopic=Content%2Fsharing_pubs.htm%7CSkinName=svs_SD>
>
>     and again in the table at the bottom of that webpage: “Public
>     posting on commercial platforms (e.g., www.researchgate.net
>     <http://www.researchgate.net>, www.academia.edu
>     <http://www.academia.edu>)” :not allowed
>
>     I’ve been asking Alicia Wise, on what grounds why Elsevier takes
>     that position. She replied:
>
>     „Both ResearchGate & academia.edu <http://academia.edu> use
>     content commercially to sell advertising & services around the
>     content they disseminate” and “Both ResearchGate & academia.edu
>     <https://t.co/IQgdiiCF1s> are problems in Germany as they go
>     beyond private use to make NC content publicly available”
>     (https://twitter.com/wisealic/status/874284792275140609
>     <https://twitter.com/wisealic/status/874284792275140609>and
>     https://twitter.com/wisealic/status/874284916644696066
>     <https://twitter.com/wisealic/status/874284916644696066> )
>
>     My interpretation of the CC licence is that sharing of CC BY-NC-ND
>     article by commercial platforms is OK as long as they don’t sell
>     the articles (which they don’t do).
>
>     But apart from that - what authors are doing is IMHO definitely
>     not prohibited because they have no commercial gain whatsoever.
>
>     What do you think?
>
>     Kind regards
>
>     Bernhard
>
>     ###########################################
>
>     Dr. Bernhard Mittermaier
>
>     Forschungszentrum Jülich GmbH
>
>     Leiter der Zentralbibliothek / Head of the Central Library
>
>     52425 Jülich
>
>     Tel ++49-2461-613013 <tel:+49%202461%20613013>
>
>     Fax ++49-2461-616103 <tel:+49%202461%20616103>
>
>     Sitz der Gesellschaft: Juelich
>     Eingetragen im Handelsregister des Amtsgerichts Dueren Nr. HR B 3498
>     Vorsitzender des Aufsichtsrats: MinDir Dr. Karl Eugen Huthmacher
>     Geschaeftsfuehrung: Prof. Dr.-Ing. Wolfgang Marquardt (Vorsitzender),
>     Karsten Beneke (stellv. Vorsitzender), Prof. Dr.-Ing. Harald Bolt,
>     Prof. Dr. Sebastian M. Schmidt
>
>
>     _______________________________________________
>     GOAL mailing list
>     GOAL at eprints.org <mailto:GOAL at eprints.org>
>     http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
>     <http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal>
>
>
>
>
> -- 
> Richard Poynder
> www.richardpoynder.co.uk <http://www.richardpoynder.co.uk>
>
>
> _______________________________________________
> GOAL mailing list
> GOAL at eprints.org
> http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal

-- 
Signature







Jevan Pipitone
MIT SE (UC), GradDip IT (UC), BSc (ANU), GradCert Rsch Methods & Des (UC)
C#.NET/VB.NET Developer, ASP.NET MySql/MS Sql C#/VB Database Driven 
Websites, IT Research, IT Support, IT Tutoring
http://www.jevan.com.au/
email1 at jevan.com.au <mailto:email1 at jevan.com.au>
Tel: (02) 6176 1285 / 0498 627 366
(+612 6176 1285 / +61 498 627 366)
Skype: jevanp
Canberra, Australia




-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mailman.ecs.soton.ac.uk/pipermail/goal/attachments/20170619/eda55e53/attachment-0001.html 
-------------- next part --------------
A non-text attachment was scrubbed...
Name: signature-jp.png
Type: image/png
Size: 753 bytes
Desc: not available
Url : http://mailman.ecs.soton.ac.uk/pipermail/goal/attachments/20170619/eda55e53/attachment-0001.png 
-------------- next part --------------
A non-text attachment was scrubbed...
Name: portrait-jevan.jpg
Type: image/jpeg
Size: 15502 bytes
Desc: not available
Url : http://mailman.ecs.soton.ac.uk/pipermail/goal/attachments/20170619/eda55e53/attachment-0002.jpg 
-------------- next part --------------
A non-text attachment was scrubbed...
Name: signature-dolphin.jpg
Type: image/jpeg
Size: 9343 bytes
Desc: not available
Url : http://mailman.ecs.soton.ac.uk/pipermail/goal/attachments/20170619/eda55e53/attachment-0003.jpg 


More information about the GOAL mailing list